Actively Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Led by Takeda · Updated on 2026-02-18
75
Participants Needed
27
Research Sites
174 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, multiple myeloma participants with secondary immunodeficiency (SID) will be treated with HyQvia according to their clinic's standard practice. The study's main aim is to look into infusion parameters of HyQvia administration.
CONDITIONS
Official Title
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able and willing to provide informed consent, or consent provided by legally authorized representative
- Diagnosed with multiple myeloma requiring systemic anti-myeloma therapy as per IMWG criteria
- Started HyQvia treatment no more than 30 days before enrollment or within 30 days after enrollment, with no more than 2 doses received
- Age 18 years or older at the time of multiple myeloma diagnosis
- Medical history available from time of multiple myeloma diagnosis requiring treatment
- Life expectancy greater than 6 months at enrollment as assessed by physician
- Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less
- Willing and able to comply with study requirements
You will not qualify if you...
- Known hypersensitivity to any components of HyQvia
- Primary immunodeficiency or diagnosed with HIV/AIDS, active hepatitis B or C infection
- Use of immunoglobulin treatment or prophylaxis within 3 months before enrollment
- Serious infections requiring intravenous treatment at enrollment, except short-term oral antibiotics
- Participation in an interventional clinical study involving medicinal products or devices within 30 days before enrollment or planned during this study (except CAR-T cell therapies or bispecific antibodies)
- Planned stem cell transplant during treatment or prior stem cell transplant: any allogeneic transplant or autologous transplant within 3 months
- History of malignancy other than multiple myeloma within 3 years before enrollment, except certain skin cancers, carcinoma in situ, localized prostate cancer, or other low-risk lesions
- Major surgery within 2 weeks before enrollment or not fully recovered from earlier surgery, or planned major surgery during study participation (local anesthesia surgeries allowed; kyphoplasty and vertebroplasty excluded)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 27 locations
1
Instituto Privado de Investigaciones Clinicas de Cordoba
Córdoba, Argentina, X5000AAW
Withdrawn
2
Fakultni nemocnice Plzen
Pilsen, Czechia, 30460
Actively Recruiting
3
Vseobecna fakultni Nemocnice
Prague, Czechia, 128 08
Not Yet Recruiting
4
CHU Amiens - Hopital Sud
Salouël, Somme, France, 80480
Actively Recruiting
5
CHU Dijon - Hopital du Bocage
Dijon, France, 21079
Not Yet Recruiting
6
Hopital Prive du Confluent
Nantes, France, 44 277
Actively Recruiting
7
Hopital de la Source - CHR Orleans
Orléans, France, 45067
Not Yet Recruiting
8
CHU Bordeaux - Hopital Haut-Leveque
Pessac, France, 33604
Not Yet Recruiting
9
MHP-Muenchner Haematologiepraxis
Berlin, Germany, 10117
Not Yet Recruiting
10
Alexandra General Hospital
Athens, Greece, 11528
Actively Recruiting
11
General Hospital of Thessaloniki "G. Papanikolaou"
Thessaloniki, Greece, 57010
Actively Recruiting
12
A.O.U.C Policlinico di Bari
Bari, Italy, 70124
Actively Recruiting
13
AOU Policlinico Rodolico San Marco
Catania, Italy, 95125
Actively Recruiting
14
Azienda Ospedale Universita Padova
Padova, Italy, 35128
Not Yet Recruiting
15
University of Padova
Treviso, Italy, 31122
Actively Recruiting
16
Pomorski Uniwersytet Medyczny
Szczecin, Poland, 71252
Actively Recruiting
17
Spitalul Clinic Colentina
Bucharest, Romania, 020125
Not Yet Recruiting
18
Institutul Clinic Fundeni
Bucharest, Romania, 22328
Not Yet Recruiting
19
Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca
Cluj-Napoca, Romania, 400015
Not Yet Recruiting
20
Spitalul Clinic Municipal Filantropia Craiova
Craiova, Romania, 200143
Not Yet Recruiting
21
Hospital Clinico San Carlos
Madrid, Spain, 28040
Actively Recruiting
22
Hospital Universitario 12 de Octubre
Madrid, Spain, 28041
Actively Recruiting
23
Hospital Universitari Son Espases
Palma, Spain, 70120
Actively Recruiting
24
Lund University Hospital
Lund, Sweden, SE-221 85
Not Yet Recruiting
25
Ankara University Medical Faculty
Ankara, Turkey (Türkiye), 06100
Actively Recruiting
26
Antalya Training and Research Hospital
Antalya, Turkey (Türkiye), 7100
Actively Recruiting
27
Istanbul Universitesi
Istanbul, Turkey (Türkiye), 34098
Not Yet Recruiting
Research Team
T
Takeda Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here